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Abstract-Mammalian AMP-activated protein kinase (AMPK) is a 
Ser108/Thr132 heterotrimeric enzyme complex (one catalytic subunit 
α and two regulatory subunits β and γ) with a key role as sensor in 
the cellular energy homeostasis. This function confers AMPK a major 
role in numerous metabolic disorders, such as type 2 diabetes, 
obesity and cancer, and explains the progressive interest as a 
therapeutic target. AMPK is regulated by several mechanisms 
including indirect and direct activators, which show clear specificity 
by a particular subunit. We have carried out a series of molecular 
dynamic simulations of the apo and holo forms of AMPK to gain 
insight into the mechanism of AMPK activation. 
I. INTRODUCTION 
Mammalian AMP-activated protein kinase (AMPK) is a 
Ser108/Thr132 protein kinase with a key role as sensor in the 
cellular energy homeostasis [1]. This function confers AMPK 
a major role in numerous metabolic disorders, such as type 2 
diabetes, obesity and cancer, and explains the progressive 
interest as a therapeutic target. AMPK is a heterotrimeric 
enzyme complex composed by a catalytic α-subunit and two 
regulatory subunits known as β and γ. It is regulated by 
several mechanisms, including indirect activators such as 
metformin, rosiglitazone and resveratrol, and direct activators, 
such as compound A-769662 [2] (Figure 1A). Some of these 
activators show a clear specificity for a particular AMPK 
subunit, which provide a possible way to design new 
compounds that could activate AMPK in specific tissues, 
minimizing the putative negative effects of AMPK activation 
at whole body level [3].  
 The X-ray structure of AMPK bound to the direct activator 
A-769662 has been recently reported (PDB entry: 4CFF) [2]. 
We have carried out a series of molecular dynamic simulations 
of the apo and holo forms of AMPK, with the phosphorylated 
Ser108 (pSer108), to gain insight into the mechanism of 
AMPK activation. The results indicate that the holo structure 
is less flexible than the apo form, most likely due to the strong 
interactions formed between pSer108 and Lys29/Lys31 upon 
binding of the activator. Furthermore, the presence of the 
activator leads to a significant alteration in the shape and size 
of the ATP-binding pocket. Moreover, this effect is linked to 
the dynamical fluctuations observed between the N-terminus 
of the catalytic α-subunit and the regulatory domain of the β-
subunit. On the basis of these results, we speculate that these 
structural and dynamical features may provide the molecular 
basis for the synergy found experimentally between the 
binding of activator and phosphorylation of pSer108 in 
regulating the activity of AMPK. 
Fig. 1.  A) 3D-structure of AMPK. B) RMSD of apo protein. C) RMSD of 
phosphorylated holo protein (complex with A769662 activator) 
II. RESULTS
A. Conformational flexibility 
MD simulations show that the complex between the 
phosphorylated Ser108 (pSer108) kinase domain of AMPK 
(pAMPK) complexed with the activator A-769662 presents an 
overall reduction in the conformational flexibility compared to 
the apo form, which is especially significant in the N-lobe 
region (Figure 1). 
B. Essential dynamics 
The apo form shows two regions with different dynamic 
behavior. One region formed by the N-terminal domain of the 
kinase and the Carbohydrate Binding Domain (CBM) located 
in the β-subunit, which show much higher flexibility than the 
rest of the structure. Remarkably, in the apo form the ATP-
binding loop presents a reduced flexibility (marked with a red 
arrow in Figure 2, top). In contrast, the dynamical behavior of 
the holo form involves a correlated movement of the N-
terminal domain of the kinase, the β-subunit and the flexible 
loop located in the upper part of the ATP-binding site (Figure 
2, bottom).  
This remarkable difference in the dynamics of the apo and 
holo forms might be related to the presence of the activator. 
Thus, we speculate that it would act like a glue, by releasing 
the water molecules present in the binding pocket and filling 
the space between the N-terminal domain of the α subunit and 
the CBM of the β subunit, and therefore, transferring the 
movement of these regions to the ATP-binding site. 
 It can be expected that the increased flexibility of the upper 
loop in the ATP-binding site should favor the population of 
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conformations suitable for accommodating ATP, which in turn 
should lead to an increase in the activity of AMPK. 
 
 
 
 
Fig. 2.  Representation of the first essential mode, which contributes between 
20-30% for apo and holo forms. 
 
  
C. Distances  
A key molecular determinant of this structural alteration is 
the residue Arg83, which is highly flexible in the apo form, 
being able to form salt bridge interactions with either Asp88 or 
Asp136. The apo form shows frequent exchange between 
those salt bridge interactions along the MD simulation in 
comparison to the holo form, where the presence of the 
activator shifts the interaction pattern toward the contact with 
Asp88. 
 The activator is tightly bound in the binding pocket. Most 
of the contacts comprise van der Waals interactions with 
hydrophobic residues, but the binding is also assisted by the 
formation of hydrogen bonds between the amide NH unit and 
the carboxylate group of the Asp88 and between the hydroxy 
unit of the phenyl ring with the carbonylic oxygen of Gly19. 
In addition, the binding of A769662 is further assisted by the 
contact between the phosphate group of pSer108 and Lys29. 
However the conformational flexibility of the phosphate group 
allows the formation of complementary interactions with 
either the hydroxyl group attached to the fused bicycle of the 
activator or with Lys31. Overall, this interaction seems 
relevant for keeping the activator tightly bound to the pocket 
at the N-terminus domain. 
 
CONCLUSIONS 
On the basis of these findings, it can be speculated that 
binding of A769662 and Ser108 phosphorylation act 
synergistically to enhance the binding of ATP. 
 At present, we hypothesize that this effect implies a sizable 
rearrangement of the binding pocket residues that would shape 
the ATP-binding site, specifically leading to a conformational 
change in the mouth of the binding pocket that would alter the 
balance between open and closed states. In turn, this effect 
should favour the binding of ATP, and the concomitant 
increase in enzymatic activity. 
 Future studies will extent these simulations to the 
complexes with bound ATP in order to ascertain the impact on 
the ATP arrangement in the binding site and the 
association/dissociation events. 
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